Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Heide, U. van der"'
Autor:
Potter, R., Tanderup, K., Kirisits, C., Leeuw, A. de, Kirchheiner, K., Nout, R., Tan, L.T., Haie-Meder, C., Mahantshetty, U., Segedin, B., Hoskin, P., Bruheim, K., Rai, B., Huang, F., Limbergen, E. van, Schmid, M., Nesvacil, N., Sturdza, A., Fokdal, L., Jensen, N.B.K., Georg, D., Assenholt, M., Seppenwoolde, Y., Nomden, C., Fortin, I., Chopra, S., Heide, U. van der, Rumpold, T., Lindegaard, J.C., Jurgenliemk-Schulz, I., Dumas, I., Chargari, C., Swamidas, J., Shrivastava, S.K., Lowe, G., Hudej, R., Hellebust, T.P., Menon, G., Oinam, A.S., Cooper, R., Bownes, P., Banasik, E.V., Sundset, M., Pieters, B., Lutgens, L.C.H.W., Villafranca, E., Hadjiev, J., Bachand, F., Erickson, B., Jacobson, G., Anttila, M., EMBRACE Collaborative Grp
Publikováno v:
EMBRACE Collaborative Group 2018, ' The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies ', Clinical and Translational Radiation Oncology, vol. 9, pp. 48-60 . https://doi.org/10.1016/j.ctro.2018.01.001
Clinical and Translational Radiation Oncology, Vol 9, Iss C, Pp 48-60 (2018)
EMBRACE Collaborative Group 2018, ' The EMBRACE II study : The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies ', Clinical and translational radiation oncology, vol. 9, pp. 48-60 . https://doi.org/10.1016/j.ctro.2018.01.001
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 9, Iss C, Pp 48-60 (2018)
EMBRACE Collaborative Group 2018, ' The EMBRACE II study : The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies ', Clinical and translational radiation oncology, vol. 9, pp. 48-60 . https://doi.org/10.1016/j.ctro.2018.01.001
Clinical and Translational Radiation Oncology
Graphical abstract
Highlights • Image guided adaptive brachytherapy (IGABT) is changing clinical practice. • The EMBRACE studies benchmark IGABT in cervix cancer. • A multi-parametric dose prescription protocol is being validated in EMBRAC
Highlights • Image guided adaptive brachytherapy (IGABT) is changing clinical practice. • The EMBRACE studies benchmark IGABT in cervix cancer. • A multi-parametric dose prescription protocol is being validated in EMBRAC
Publikováno v:
Photochemistry & Photobiology; May1989, Vol. 49 Issue 5, p663-672, 10p